Search

Your search keyword '"Cutrupi, S."' showing total 268 results
Start Over Author "Cutrupi, S."
268 results on '"Cutrupi, S."'

18. CKD GENERAL AND CLINICAL EPIDEMIOLOGY 2

Author

Davids, M. R., Marais, N., Jacobs, J., Cohen, E., Krause, I., Goldberg, E., Garty, M., Dursun, B., Sahan, Y., Tanriverdi, H., Rota, S., Uslu, S., Senol, H., Minutolo, R., Gabbai, F. B., Agarwal, R., Chiodini, P., Borrelli, S., Stanzione, G., Nappi, F., Bellizzi, V., Conte, G., Nicola, L. D., J. V., De, Johnson, S., Fremeaux Bacchi, V., Ardissino, G., Ariceta, G., Beauchamp, J., Cohen, D., Greenbaum, L. A., Ogawa, M., Schaefer, F., Licht, C., Scalzotto, E., Nalesso, F., Zaglia, T., Corradi, V., Neri, M., Martino, F., Zanella, M., Brendolan, A., Mongillo, M., Ronco, C., Chinnappa, S., Mooney, A., A. M., El, Y. K., Tu, Tan, L. B., Jung, J. Y., Kim, A. J., Ro, H., Lee, C., Chang, J. H., Lee, H. H., Chung, W., Clarke, A. L., Young, H. M., Hull, K. L., Hudson, N., Burton, J. O., Smith, A. C., Marx, S., Petrilla, A., Filipovic, I., Lee, W. C., Meijers, B., Poesen, R., Storr, M., Claes, K., Kuypers, D., Evenepoel, P., Aukland, M., Betriu, A., Martinez Alonso, M., Arcidiacono, M. V., Cannata Andia, J., Pascual, J., Valdivielso, J. M., Fernandez Giraldez, E., Kingswood, J. C., Zonnenberg, B., Sauter, M., Zakar, G., Biro, B., Besenczi, B., Varga, A., Pekacs, P., Pizzini, P., Pisano, A., Leonardis, D., Panuccio, V., Cutrupi, S., Tripepi, G., Mallamaci, F., Zoccali, C., Arnold, J., Baharani, J., Rayner, H., B. H., So, Blackwell, S., Jardine, A. G., Macgregor, M. S., Cunha, C., Barreto, P., Pereira, S., Ventura, A., Mota, M., Seabra, J., Sakaguchi, T., Kobayashi, S., Yano, T., Yoshimoto, W., Bancu, I., Bastons, J. B., Escayola, M. C., Vallespin, E. V., Poblet, M. B., Luque, D. M., Fabregas, M. P., Chen, J., Chen, S., Chang, J., Hwang, S., Chen, H., Ahbap, E., Kara, E., Basturk, T., Sahutoglu, T., Koc, Y., Sakaci, T., Sevinc, M., Akgol, C., Ozagari, A. A., Unsal, A., Minami, S., Hesaka, A., Yamaguchi, S., Iwahashi, E., Sakai, S., Fujimoto, T., Sasaki, K., Fujita, Y., Yokoyama, K., Marks, A., Fluck, N., Prescott, G., Robertson, L., Smith, W. C., Black, C., Ohsawa, M., Fujioka, T., Omori, S., Isurugi, T., Tanno, K., Onoda, T., Omama, S., Ishibashi, Y., Makita, S., Okayama, A., Garland, J. S., Simpson, C. S., Metangi, M. F., Parfrey, B., Johri, A. M., Sloan, L., Mcauley, J., Cunningham, R., Mullan, R., Quinn, M., Harron, C., Chiu, H., Murphy Burke, D., Werb, R., Jung, B., Chan Yan, C., Duncan, J., Forzley, B., Lowry, R., Hargrove, G., Carson, R., Levin, A., Karim, M., Reznik, E. V., G. I. V., Rollino, C., Troiano, M., Bagatella, M., Liuzzo, C., Quarello, F., Roccatello, D., Blaslov, K., Bulum, T., Prkacin, I., Duvnjak, L., Heleniak, Z., Cieplinska, M., Szychlinski, T., Pryczkowska, M., Bartosinska, E., Wiatr, H., Kotlowska, H., Tylicki, L., Rutkowski, B., Song, Y. R., Kim, S. G., Kim, H. J., Noh, J. W., Tong, A., Jesudason, S., Craig, J. C., Winkelmayer, W. C., Hung, P. H., Huang, Y. T., Hsiao, C. Y., Sung, P. S., Guo, H. R., Tsai, K. J., Wu, C., Su, S., Kao, S., Lu, K., Lin, Y., Lin, W., Lee, H., Cheng, M., Wang, W., Yang, L., Wang, M., Lela, I. V., Sekoranja, M., Poljicanin, T., Karanovic, S., Abramovic, M., Matijevic, V., Stipancic, Z., Leko, N., Cvitkovic, A., Dika, Z., Kos, J., Laganovic, M., Grollman, A. P., Jelakovic, B., Dryl Rydzynska, T., Prystacki, T., Malyszko, J., Trifiro', Gianluca, Sultana, J., Giorgianni, F., Ingrasciotta, Y., Muscianisi, M., Tari, D. U., Perrotta, M., Buemi, Michele, Canale, V., Arcoraci, Vincenzo, Santoro, Domenico, Rizzo, M., Iheanacho, I., Van, F. E., Goldsmith, D., Grandtnerova, B., Beratsova, Z., Cervenˇova, M., Cˇervenˇ, J., Markech, M., Stefanikova, A., Engelen, W., Elseviers, M., Gheuens, E., Colson, C., Muyshondt, I., and Daelemans, R.

Subjects
Transplantation, medicine.medical_specialty, business.industry, urologic and male genital diseases, medicine.disease, Gastroenterology, female genital diseases and pregnancy complications, Nephrology, Internal medicine, mental disorders, Medicine, Stage (cooking), Metabolic syndrome, business, Kidney disease
Published
2014
Full Text
View/download PDF

22. Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease

Author

Zoccali, C, Mallamaci, F, Tripepi, G, Parlongo, S, Cutrupi, S, Benedetto, Fa, Cataliotti, A, Malatino, L, on Behalf of the Creed Investigator, Rapisarda, F., and Fatuzzo, P.

Subjects
Adult, Male, medicine.medical_specialty, Heart disease, Concentric hypertrophy, Left ventricular hypertrophy, Muscle hypertrophy, End stage renal disease, Cohort Studies, Norepinephrine, Renal Dialysis, Internal medicine, Internal Medicine, Humans, Medicine, Aged, business.industry, Hypertrophic cardiomyopathy, Middle Aged, medicine.disease, Endocrinology, medicine.anatomical_structure, Ventricle, Cardiology, Kidney Failure, Chronic, Regression Analysis, Female, Hypertrophy, Left Ventricular, business, Kidney disease
Abstract

We have recently observed that in patients with end-stage renal disease (ESRD) raised plasma norepinephrine (NE) is an independent predictor of incident cardiovascular events but that its prognostic power is reduced when this sympathetic marker is tested in statistical models including also left ventricular mass. Because left ventricular hypertrophy (LVH) may be a mechanism whereby NE contributes to the high rate of cardiovascular events in ESRD, we examined the relationship between plasma NE and echocardiographic parameters of left ventricle mass in a large group of ESRD patients. Mean wall thickness (MWT) was higher in patients in the third NE tertile than in the other 2 tertiles ( P =0.001), and such an increase was paralleled by a rise in relative wall thickness (RWT) ( P =0.006). Concentric LVH was more prevalent in patients in the third NE tertile (46%) than in the second (38%) and first (25%) NE tertiles. Multivariate regression analysis confirmed that the association of plasma NE with the muscular component of left ventricle (MWT) and with RWT was independent ( P ≤0.001) of other cardiovascular risk factors, and in these models, plasma NE ranked as the second correlate of MWT and RWT. Similarly, multiple logistic regression analysis showed that the association of plasma NE with concentric LVH was strong and again independent of other risk factors ( P =0.003). Plasma NE is associated to concentric LVH in ESRD patients. These observations constitute a sound basis for testing the effect of anti-adrenergic drugs on left ventricle mass and on cardiovascular outcomes in patients with ESRD.

Published
2002
Full Text
View/download PDF

27. Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild hypertension

Author

CUZZOLA F, TRIPEPI G, MALLAMACI F, PARLONGO S, CUTRUPI S, CATALIOTTI A, STANCANELLI B, MALATINO L, BELLANUOVA I, ZOCCALI C., SALT SENSITIVITY GROUP OF THE ITALIAN SOCIETY OF, STRAZZULLO, PASQUALE, Cuzzola, F, Tripepi, G, Mallamaci, F, Parlongo, S, Cutrupi, S, Cataliotti, A, Stancanelli, B, Malatino, L, Bellanuova, I, Strazzullo, Pasquale, Zoccali, C., and SALT SENSITIVITY GROUP OF THE ITALIAN SOCIETY, Of

Abstract

Altri autori:Ferri C, Galletti F, Filigheddu F, Glorioso N

Published
2001

30. Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hyperthrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3) J. of Endocrinol. Invest., 23, 724-6, 2000 IF: 0.96

Author

GRANATA R., BROGLIO F., MIGLIORINO D., CUTRUPI S., BALDANZI G., SIRENO M, FUBINI A., GHIGO E, PUCCI A., GRAZIANI , ANDREA, Granata, R., Broglio, F., Migliorino, D., Cutrupi, S., Baldanzi, G., Sireno, M, Fubini, A., Graziani, Andrea, Ghigo, E, and Pucci, A.

Published
2000

32. Genome-wide analysis of unliganded estrogen receptor binding sites in breast cancer cells

Author

Caizzi, L., Cutrupi, S., Testori, A., Cora, D., Cordero, F., Friard, O., Ballare, C., Porporato, R., Giurato, Giorgio, Weisz, Alessandro, Medico, E., Caselle, M., Di Croce, L., and De Bortoli, M.

Subjects
breast cancer, estrogen receptor alpha, chromatin immunoprecipitation sequencing, genomics, methods, Estrogen Receptor alpha, methods
Published
2011

33. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD

Author

Spoto, B.G. (Belinda), Mattace Raso, F.U.S. (Francesco), Sijbrands, E.J.G. (Eric), Leonardis, D. (Daniela), Testa, A. (Alessandra), Pisano, A. (Anna), Pizzini, P. (Patrizia), Cutrupi, S. (Sebastiano), Parlongo, R.M. (Rosa), D’Arrigo, G. (Graziella), Tripepi, G.L. (Giovanni), Mallamaci, F. (Francesca), Zoccali, C. (Carmine), Spoto, B.G. (Belinda), Mattace Raso, F.U.S. (Francesco), Sijbrands, E.J.G. (Eric), Leonardis, D. (Daniela), Testa, A. (Alessandra), Pisano, A. (Anna), Pizzini, P. (Patrizia), Cutrupi, S. (Sebastiano), Parlongo, R.M. (Rosa), D’Arrigo, G. (Graziella), Tripepi, G.L. (Giovanni), Mallamaci, F. (Francesca), and Zoccali, C. (Carmine)

Abstract

Background and objectives High serumIL-6 is amajor risk factor for cardiovascular disease (CVD) in the general population. This cytokine is substantially increased in patientswith CKD, but it is still unknownwhether the link between IL-6 and CVD in CKD is causal in nature. Design, setting, participants, & measurements In a cohort of 755 patientswith stages 2–5 CKD, consecutively recruited from 22 nephrology units in southern Italy, this study assessed the relationship of serum IL-6 with history of CVD, as well as with incident cardiovascular (CV) events (mean follow up6SD, 31610 months) and used the functional polymorphism (2174 G/C) in the promoter of the IL-6 gene to investigate whether the link between IL-6 and CV events is causal. Results In adjusted analyses, serum IL-6 above the median value was associated with history of CVD (P,0.001) and predicted the incidence rate of CV events (hazard ratio, 1.66; 95% confidence interval [95% CI], 1.11 to 2.49; P=0.01). Patients homozygous for the risk allele (C) of the2174G/C polymorphismhad higher levels of IL-6 than did those with other genotypes (P=0.04). Homozygous CC patients more frequently had a history of CVD (odds ratio, 2.15; 95%CI, 1.15 to 4.00; P=0.02) as well as a 87%higher rate of incident CV events (hazard ratio, 1.87

Published
2015
Full Text
View/download PDF

34. C-reactive protein, brain natriuretic peptide, and asymmetric dimethyl arginine combined may play a key diagnostic role: prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD

Author

Mallamaci, F., Tripepi, G., and Cutrupi, S.

Subjects
Natriuretic peptides -- Research, Chronic kidney failure -- Diagnosis, Chronic kidney failure -- Care and treatment, Chronic kidney failure -- Risk factors, Chronic kidney failure -- Research, Health
Published
2006

50. Completing transition: The main challenges

Author

Sergi, Bruno Sergio, Benedetto, Fa, Mallamaci, F, Tripepi, G, Cutrupi, S, Parlongo, S, Malatino, Ls, Bonanno, G, Rapisarda, F, Fatuzzo, P, Seminara, G, Nicocia, Giacomo, and Buemi, Michele

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results